Northwest Investment Counselors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Northwest Investment Counselors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,013	Closed	-$41.5K	–	587
2022 Q4	$41.5K	Buy	1,013 +5	+0.5%	+$208	0.01%	260
2022 Q3	$40K	Buy	1,008 +3	+0.3%	+$128	0.01%	238
2022 Q2	$42K	Buy	1,005 +4	+0.4%	+$168	0.01%	233
2022 Q1	$45K	Buy	1,001 +4	+0.4%	+$176	0.01%	241
2021 Q4	$46K	Buy	+997	New	+$47.2K	0.01%	238
2021 Q2	–	Sell	-990	Closed	-$50K	–	460
2021 Q1	$50K	Buy	+990	New	+$52.8K	0.01%	219
2017 Q4	–	Sell	-1,156	Closed	-$49K	–	318
2017 Q3	$49K	Buy	+1,156	New	+$49K	0.02%	182

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Northwest Investment Counselors's XPH Position: Q1 2023 in Review

Northwest Investment Counselors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2023, closing a stake of 1,013 shares — an estimated $41.5K sold.

Northwest Investment Counselors first reported a position in XPH in Q3 2017 and held it in 7 quarters. The position peaked at $50K in Q1 2021. 61 funds tracked by Wall St. Rank hold XPH as of Q1 2023.

Northwest Investment Counselors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2023 after selling out during the quarter.
Northwest Investment Counselors sold 1,013 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2023, an estimated $41.5K.
Northwest Investment Counselors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2017 and held it in 7 quarters.
Northwest Investment Counselors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $50K in Q1 2021.
61 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2023.

Based on Northwest Investment Counselors's 13F filing for Q1 2023, filed 17 Apr 2023.